ARCA biopharma Inc

NASDAQ:ABIO  
2.38
+0.06 (+2.59%)
Earnings Announcements

ARCA Biopharma Announces Q2 2022 Financial Results

Published: 08/02/2022 21:37 GMT
ARCA biopharma Inc (ABIO) - Arca Biopharma Announces Second Quarter 2022 Financial Results.
Q2 Loss per Share $0.22.
Arca Biopharma - Believes Its Current Cash and Cash Equivalents, Will Be Sufficient to Fund Operations at Current Levels Through at Least End of 2023.
Cash and Cash Equivalents Were $46.4 Million As of June 30, 2022, Compared to $53.4 Million As of December 31, 2021.